{
    "nctId": "NCT01796444",
    "briefTitle": "Axillary Lymph Node Dissection Versus no Dissection in Breast Cancer With Positive Sentinel Lymph Node",
    "officialTitle": "A Prospective Randomized Multicenter Phase III Study of Axillary Lymph Node Dissection Versus no Dissection in Breast Cancer With Positive Sentinel Lymph Node--the Validation of Z0011 in China",
    "overallStatus": "WITHDRAWN",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE3",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 0,
    "primaryOutcomeMeasure": "Disease Free Survival",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Female;\n* Patient aged 18 years and above;\n* Patient with histological proven invasive breast cancer;\n* Clinical T1-T2 disease with no distant metastasis;\n* Patient with clinical N0 status;\n* Patient for whom conservative surgery with sentinel lymph node (SLN) technique is feasible from the start in terms of carcinologic;\n* Patient with positive SLNs 1\\~2;\n* Signed consent to participate.\n\nExclusion Criteria:\n\n* History of neoadjuvant chemotherapy or hormone therapy;\n* History of breast cancer (ipsilateral, i.e. recurrence, or contralateral breast);\n* History of any other invasive cancer;\n* Initial metastatic disease known;\n* Pregnant women or lactating women;\n* Impossibility to undergo medical examinations of the study for geographical, social or psychological reasons.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}